Effects of blood pressure and glucose on endothelial function

Current Hypertension Reports

Volumn 3, Issue 1, 2001, Pages 79-88

  Cosentino, Francesco ^a,b   Lüscher, Thomas F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL MODEL; BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MODELS, ANIMAL;

EID: 0035256746     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0085-8     Document Type: Article

References (55)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature 1980, 288: 373-376.
2. Cosentino F, Luscher TF: Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators. Eur Heart J 1995, 16(K):4-12.
3. MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke and coronary heart disease. Part I: Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335: 765-774.
4. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 1978, 241: 2035-2038.
5. Laasko M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diab Rev 1997, 5: 294-315.
6. Laasko M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999, 48: 937-948.
7. Rees DD, Palmer RMJ, Moncada S: Role of endotheliumderived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 1989, 86: 3375-3378.
8. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362: 801-809.
9. Cosentino F, Luscher TF: Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res 1999, 43: 274-278.
10. Wever RMF, Luscher TF, Cosentino F, et al.: Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998, 97: 108-112.
11. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43: 109-142.
12. Luscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. Boca Raton, FL: CRC Press; 1990.
13. Kelm M, Feelisch M, Krebber T, et al.: The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1992, 20: 183-186.
14. Nava E, Noll G, Luscher TF: Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 1995, 91: 2310-2323.
15. Nakazono K, Watanabe N, Matsuno K, et al.: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 1991, 88: 10045-10048.
16. Cosentino F, Patton S, D'Uscio LV, et al.: Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998, 101: 1530-1537.
17. Moreau P, Takase H, Kung CF, et al.: Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension 1997, 29: 763-769.
18. Linder L, Kiowski W, Buhler FR, et al.: Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in hypertension. Circulation 1990, 81: 1762-1767.
19. Panza JA, Quyyumi AA, Brush JH Jr, et al.: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323: 22-27.
20. Treasure CB, Manoukian SV, Klein GL, et al.: Epicardial coronary artery responsee to acetylcholine are impaired in hypertensive patients. Circ Res 1992, 71: 776-781.
21. Egashira K, Suzuki S, Hirooka Y, et al.: Impaired endotheliumdependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Circulation 1995, 25: 201-206.
22. Li J, Zaho S P, Li X P, et al.: Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997, 61: 165-169.
23. Forte P, Copland M, Smith LM, et al.: Basal nitric oxide synthesis in essential hypertension. Lancet 1997, 349: 837-842.
24. Cockroft JR, Chowienczyck PJ, Benjamin N, et al.: Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med 1994, 300: 1036-1040.
25. Brunig TA, Chang PC, Hendricks GC, et al.: In vivo characterization of muscarinic receptors subtypes that mediate vasodilation in patients with essential hypertension. Hypertension 1995, 26: 70-77.
26. Taddei S, Virdis A, Mattei P, et al.: Vasodilation to acetylcholine in primary and secondary forms of hypertension. Hypertension 1993, 21: 929-933.
27. Taddei S, Virdis A, Mattei P, et al.: Hypertension causes premature aging of endothelial function in humans. Hypertension 1997, 29: 736-743.
28. Taddei S, Virdis A, Ghiadoni L, et al.: Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997, 29: 274-279.
29. Solzbach U, Horning B, Jeserisch M, et al.: Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997, 96: 1513-1519.
30. Taddei S, Virdis A, Mattei P, et al.: Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996, 94: 1298-1303.
31. Tesfamariam B, Jakubowski JA, Cohen RA: Contraction of diabetic rabbit aorta due to endothelium-derived PGH2/TXA2. Am J Physiol 1989, 257: H13272-H13277.
32. Mayhan W, Simmons LK, Sharpe QM: Mechanisms of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 1991, 260: H319-H326.
33. Tesfamariam B, Brown ML, Deykin D, et al.: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990, 85: 929-932.
34. Tesfamariam B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein chinase C. J Clin Invest 1991, 87: 1643-1648.
35. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992, 263: H321-H323.
36. Hattori Y, Kawasaki H, Abe K, et al.: Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1991, 261: H1086-H1094.
37. Saenz De Tejada I, Goldstein I, Azadzoi K, et al.: Impaired neurogenic and endothelium-dependent relaxation of human penile smooth muscle: the pathophysiological basis for impotence in diabetes mellitus. N Engl J Med 1989, 320: 1025-1030.
38. Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992, 90: 2548-2554.
39. Elliot TG, Cockroft JR, Groop PH, et al.: Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993, 85: 687-693.
40. Johnstone MT, Craeger SJ, Scales KM, et al.: Impaired endothelium-dependent vasodilation in patients with insulindependent diabetes mellitus. Circulation 1993, 88: 2510-2516.
41. McVeigh GE, Brennan GM, Johnston BJ, et al.: Impaired endothelium-dependent and -independent vasodilation in patients with type 2 diabetes mellitus. Diabetologia 1992, 35: 771-776.
42. Enderle MD, Benda N, Schmuelling RM, et al.: Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care 1998, 21: 271-277.
43. Arcaro G, Zenere BM, Saggiani F, et al.: ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 1999, 22: 1536-1542.
44. Ting HH, Timimi FK, Boles KS, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996, 97: 22-28.
45. Timimi FK, Ting HH, Haley EA, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998, 31: 552-557.
46. Cosentino F, Hishikawa K, Katusic ZS, et al.: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96: 25-28.
47. Tesfamariam B: Free radicals in diabetic endothelial dysfunction. Free Radic Biol Med 1994, 16: 383-391.
48. Katusic ZS, Schugel J, Cosentino F, et al.: Endotheliumdependent contractions to oxygen-derived free radicals in canine basilar arteries. Am J Physiol 1993, 264: H859-H864.
49. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47: 859-866.
50. Wu KK, Hatsakis H, Lo SS, et al.: Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol esters. J Biol Chem 1988, 263: 19043-19047.
51. Robinson JM, Badwey JA, Karnovski ML, et al.: Superoxide release by neutrophils: synergistic effects of a phorbol ester and a calcium ionophore. Biochem Biophys Res Commun 1984, 122: 734-739.
52. Miyata T, Van Ypersele De Strihou C, Kurokawa K, et al.: Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long term uremic complications. Kidney Int 1999, 55: 389-399.
53. Schmidt AM, Yan SD, Wautier JL, et al.: Activation of receptor for advance glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999, 84: 489-497.
54. Vlassara H, Fuh H, Makita Z, et al.: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and ageing complications. Proc Natl Acad Sci U S A 1992, 89: 12043-12047.
55. Braunwald E: Heart Disease. Philadelphia: WB Saunders; 1997.